S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.65 (+0.74%)
AAPL   116.10 (+0.81%)
MSFT   214.00 (+0.07%)
FB   275.67 (-0.45%)
GOOGL   1,767.49 (+0.20%)
AMZN   3,188.35 (+2.25%)
TSLA   573.50 (+3.26%)
NVDA   529.50 (+2.16%)
BABA   277.50 (-0.88%)
CGC   26.84 (-0.48%)
GE   10.47 (+0.19%)
MU   63.42 (-0.83%)
AMD   86.67 (+1.88%)
T   28.99 (-0.82%)
NIO   53.95 (+0.82%)
F   9.09 (-3.81%)
ACB   8.72 (-5.53%)
NFLX   484.50 (+0.34%)
GILD   59.50 (-1.24%)
BA   217.62 (-0.40%)
DIS   149.05 (-1.61%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.65 (+0.74%)
AAPL   116.10 (+0.81%)
MSFT   214.00 (+0.07%)
FB   275.67 (-0.45%)
GOOGL   1,767.49 (+0.20%)
AMZN   3,188.35 (+2.25%)
TSLA   573.50 (+3.26%)
NVDA   529.50 (+2.16%)
BABA   277.50 (-0.88%)
CGC   26.84 (-0.48%)
GE   10.47 (+0.19%)
MU   63.42 (-0.83%)
AMD   86.67 (+1.88%)
T   28.99 (-0.82%)
NIO   53.95 (+0.82%)
F   9.09 (-3.81%)
ACB   8.72 (-5.53%)
NFLX   484.50 (+0.34%)
GILD   59.50 (-1.24%)
BA   217.62 (-0.40%)
DIS   149.05 (-1.61%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.65 (+0.74%)
AAPL   116.10 (+0.81%)
MSFT   214.00 (+0.07%)
FB   275.67 (-0.45%)
GOOGL   1,767.49 (+0.20%)
AMZN   3,188.35 (+2.25%)
TSLA   573.50 (+3.26%)
NVDA   529.50 (+2.16%)
BABA   277.50 (-0.88%)
CGC   26.84 (-0.48%)
GE   10.47 (+0.19%)
MU   63.42 (-0.83%)
AMD   86.67 (+1.88%)
T   28.99 (-0.82%)
NIO   53.95 (+0.82%)
F   9.09 (-3.81%)
ACB   8.72 (-5.53%)
NFLX   484.50 (+0.34%)
GILD   59.50 (-1.24%)
BA   217.62 (-0.40%)
DIS   149.05 (-1.61%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.65 (+0.74%)
AAPL   116.10 (+0.81%)
MSFT   214.00 (+0.07%)
FB   275.67 (-0.45%)
GOOGL   1,767.49 (+0.20%)
AMZN   3,188.35 (+2.25%)
TSLA   573.50 (+3.26%)
NVDA   529.50 (+2.16%)
BABA   277.50 (-0.88%)
CGC   26.84 (-0.48%)
GE   10.47 (+0.19%)
MU   63.42 (-0.83%)
AMD   86.67 (+1.88%)
T   28.99 (-0.82%)
NIO   53.95 (+0.82%)
F   9.09 (-3.81%)
ACB   8.72 (-5.53%)
NFLX   484.50 (+0.34%)
GILD   59.50 (-1.24%)
BA   217.62 (-0.40%)
DIS   149.05 (-1.61%)
Log in
NASDAQ:RTTR

Ritter Pharmaceuticals News Headlines

$3.30
-0.04 (-1.20 %)
(As of 11/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.16
Now: $3.30
$3.37
50-Day Range
$0.45
MA: $3.84
$5.23
52-Week Range
$0.15
Now: $3.30
$1.27
Volume1.13 million shs
Average Volume14.23 million shs
Market Capitalization$152.30 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.43

Headlines

Ritter Pharmaceuticals (NASDAQ RTTR) News Headlines Today

Source:
SourceHeadline
Ritter Pharmaceuticals (NASDAQ:RTTR) Stock Price Passes Below 50-Day Moving Average of $4.22Ritter Pharmaceuticals (NASDAQ:RTTR) Stock Price Passes Below 50-Day Moving Average of $4.22
americanbankingnews.com - November 14 at 3:32 AM
Ritter Pharmaceuticals (NASDAQ:RTTR) Stock Price Passes Below 50 Day Moving Average of $4.47Ritter Pharmaceuticals (NASDAQ:RTTR) Stock Price Passes Below 50 Day Moving Average of $4.47
americanbankingnews.com - November 6 at 4:20 AM
Qualigen Therapeutics Signs Exclusive License Agreement with the University of Louisville, Plans to Develop AS1411 for the Treatment of COVID-19Qualigen Therapeutics Signs Exclusive License Agreement with the University of Louisville, Plans to Develop AS1411 for the Treatment of COVID-19
finance.yahoo.com - June 10 at 12:24 PM
Qualigen Therapeutics Receives U.S. Patent Notice of Allowance for its STARS™ TechnologyQualigen Therapeutics Receives U.S. Patent Notice of Allowance for its STARS™ Technology
finance.yahoo.com - June 4 at 9:31 AM
Qualigen Therapeutics Announces Merger ClosingQualigen Therapeutics Announces Merger Closing
www.prnewswire.com - May 26 at 8:56 AM
Ritter to complete Qualigen tie-up todayRitter to complete Qualigen tie-up today
seekingalpha.com - May 22 at 2:28 PM
Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc.Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc.
finance.yahoo.com - May 22 at 2:28 PM
Ritter Pharmaceuticals, Inc. Announces Stockholder Approval of Proposals Required for Merger Transaction with Qualigen, Inc.Ritter Pharmaceuticals, Inc. Announces Stockholder Approval of Proposals Required for Merger Transaction with Qualigen, Inc.
finance.yahoo.com - May 19 at 1:05 PM
Ritter Pharmaceuticals, Inc. Announces Adjournment of its Special MeetingRitter Pharmaceuticals, Inc. Announces Adjournment of its Special Meeting
finance.yahoo.com - May 14 at 6:30 PM
Ritter Pharmaceuticals Regains Compliance with Nasdaqs Stockholders Equity Requirement for Continued ListingRitter Pharmaceuticals Regains Compliance with Nasdaq's Stockholders' Equity Requirement for Continued Listing
www.benzinga.com - May 11 at 9:21 AM
Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Stockholders’ Equity Requirement for Continued ListingRitter Pharmaceuticals Regains Compliance with Nasdaq’s Stockholders’ Equity Requirement for Continued Listing
finance.yahoo.com - May 11 at 9:21 AM
RTTR Ritter Pharmaceuticals, Inc. Common StockRTTR Ritter Pharmaceuticals, Inc. Common Stock
www.nasdaq.com - May 7 at 5:36 PM
66 Biggest Movers From Yesterday66 Biggest Movers From Yesterday
www.msn.com - May 7 at 7:35 AM
Thinking about buying stock in Stemline Therapeutics, KLX Energy, Trinity Biotech, Tilray, or Ritter Pharmaceuticals?Thinking about buying stock in Stemline Therapeutics, KLX Energy, Trinity Biotech, Tilray, or Ritter Pharmaceuticals?
www.benzinga.com - May 7 at 12:06 AM
Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each of the Merger ProposalsLeading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each of the Merger Proposals
finance.yahoo.com - May 6 at 12:28 PM
Ritter Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2020Ritter Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2020
finance.yahoo.com - May 1 at 9:38 PM
Ritter Pharmaceuticals, Inc. Urges Stockholders to Vote Now on Proposed Merger with Biotech Company, Qualigen Inc.Ritter Pharmaceuticals, Inc. Urges Stockholders to Vote Now on Proposed Merger with Biotech Company, Qualigen Inc.
finance.yahoo.com - April 28 at 7:58 AM
Ritter Pharmaceuticals, Inc. Announces Form S-4 Registration Statement Declared Effective by SECRitter Pharmaceuticals, Inc. Announces Form S-4 Registration Statement Declared Effective by SEC
finance.yahoo.com - April 16 at 5:50 PM
Ritter Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2019Ritter Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2019
finance.yahoo.com - March 31 at 9:41 PM
Ritter Pharmaceuticals Inc.Ritter Pharmaceuticals Inc.
www.barrons.com - March 27 at 11:17 PM
Ritter Pharmaceuticals Announces Appointment of John W. Beck as Chief Financial OfficerRitter Pharmaceuticals Announces Appointment of John W. Beck as Chief Financial Officer
www.bloomberg.com - March 4 at 7:50 PM
Thinking about buying stock in Kohls, Plug Power, Ritter Pharmaceuticals, AT&T, or Wells Fargo?Thinking about buying stock in Kohl's, Plug Power, Ritter Pharmaceuticals, AT&T, or Wells Fargo?
www.prnewswire.com - March 3 at 12:19 PM
Ritter Pharma to merger with Qualigen; shares up 28%Ritter Pharma to merger with Qualigen; shares up 28%
seekingalpha.com - January 21 at 4:51 PM
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger AgreementRitter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
finance.yahoo.com - January 21 at 4:51 PM
50 Healthcare Stocks Moving In Wednesdays Pre-Market Session50 Healthcare Stocks Moving In Wednesday's Pre-Market Session
www.msn.com - January 8 at 12:51 PM
Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for LactoseRitter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose
www.bloomberg.com - December 23 at 1:18 PM
Ritter Pharmaceuticals, Inc. Common Stock (RTTR) Institutional HoldingsRitter Pharmaceuticals, Inc. Common Stock (RTTR) Institutional Holdings
www.nasdaq.com - November 21 at 10:20 PM
What Kind Of Investor Owns Most Of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR)?What Kind Of Investor Owns Most Of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR)?
finance.yahoo.com - November 19 at 1:50 PM
Ritter Pharmaceuticals Reports Financial Results...Ritter Pharmaceuticals Reports Financial Results...
www.benzinga.com - November 13 at 10:57 PM
Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2019 and Provides Business UpdateRitter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2019 and Provides Business Update
finance.yahoo.com - November 13 at 10:57 PM
Ritter Pharmaceuticals Engages Financial Advisor to Explore Strategic AlternativesRitter Pharmaceuticals Engages Financial Advisor to Explore Strategic Alternatives
finance.yahoo.com - October 7 at 9:39 AM
What Kind Of Share Price Volatility Should You Expect For Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR)?What Kind Of Share Price Volatility Should You Expect For Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR)?
finance.yahoo.com - September 20 at 4:07 PM
Ritter Pharmas RP-G28 flunks late-stage studyRitter Pharma's RP-G28 flunks late-stage study
seekingalpha.com - September 13 at 2:31 PM
MCF, RTTR among premarket losersMCF, RTTR among premarket losers
seekingalpha.com - September 13 at 2:31 PM
Investors Push Ritter Pharma Shares To Record Low Over Failed Lactose Intolerance Drug TrialInvestors Push Ritter Pharma Shares To Record Low Over Failed Lactose Intolerance Drug Trial
www.benzinga.com - September 13 at 2:31 PM
Ritter Pharmaceuticals, Inc. (RTTR)Ritter Pharmaceuticals, Inc. (RTTR)
finance.yahoo.com - September 13 at 2:31 PM
Ritter Pharmaceuticals EPS beats by $0.18Ritter Pharmaceuticals EPS beats by $0.18
seekingalpha.com - August 14 at 9:26 PM
Ritter Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2019 and Provides a Corporate UpdateRitter Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2019 and Provides a Corporate Update
finance.yahoo.com - August 14 at 9:26 PM
Ritter Pharmaceuticals Appoints Esteemed Gastroenterologist Anthony J. Lembo, M.D. to its Medical Advisory BoardRitter Pharmaceuticals Appoints Esteemed Gastroenterologist Anthony J. Lembo, M.D. to its Medical Advisory Board
finance.yahoo.com - August 13 at 12:19 PM
Ritter Pharmaceuticals Provides Highlights from Lactose Intolerance Market Research CallRitter Pharmaceuticals Provides Highlights from Lactose Intolerance Market Research Call
finance.yahoo.com - August 8 at 5:04 PM
Ritter Pharmaceuticals Hosts Conference Call on August 7, 2019 to Highlight Recent Lactose Intolerance Market Research FindingsRitter Pharmaceuticals Hosts Conference Call on August 7, 2019 to Highlight Recent Lactose Intolerance Market Research Findings
finance.yahoo.com - July 31 at 11:59 AM
Did You Manage To Avoid Ritter Pharmaceuticalss (NASDAQ:RTTR) Devastating 93% Share Price Drop?Did You Manage To Avoid Ritter Pharmaceuticals's (NASDAQ:RTTR) Devastating 93% Share Price Drop?
finance.yahoo.com - July 12 at 4:44 PM
Did You Manage To Avoid Ritter Pharmaceuticals's (NASDAQ:RTTR) Devastating 93% Share Price Drop?Did You Manage To Avoid Ritter Pharmaceuticals's (NASDAQ:RTTR) Devastating 93% Share Price Drop?
finance.yahoo.com - July 12 at 4:44 PM
Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Minimum Bid Price RequirementRitter Pharmaceuticals Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
finance.yahoo.com - July 12 at 10:19 AM
Ritter up 6% premarket on advancement of RP-G28Ritter up 6% premarket on advancement of RP-G28
seekingalpha.com - July 2 at 10:55 AM
Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose IntoleranceRitter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose Intolerance
finance.yahoo.com - July 2 at 10:55 AM
Ritter Pharmaceuticals Provides Phase 3 Liberatus Clinical Trial and Regulatory UpdateRitter Pharmaceuticals Provides Phase 3 Liberatus Clinical Trial and Regulatory Update
finance.yahoo.com - June 20 at 11:02 AM
Ritter Pharmaceuticals Shares New Market Research Illuminating the Life Challenges of a Lactose Intolerance SuffererRitter Pharmaceuticals Shares New Market Research Illuminating the Life Challenges of a Lactose Intolerance Sufferer
finance.yahoo.com - May 30 at 11:11 AM
Ritter Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019Ritter Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019
finance.yahoo.com - May 15 at 11:29 AM
Ritter up 21% on advancement of lactose intolerance candidate RP-G28Ritter up 21% on advancement of lactose intolerance candidate RP-G28
seekingalpha.com - May 7 at 4:29 PM
This page was last updated on 11/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.